| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |